Computerized Thermal Imaging (CTI) has chosen Peak Industries of Frederick, CO, to manufacture the patient examination bed for its breast cancer detection system. The system uses thermal imaging technology to help users determine whether abnormalities
Computerized Thermal Imaging (CTI) has chosen Peak Industries of Frederick, CO, to manufacture the patient examination bed for its breast cancer detection system. The system uses thermal imaging technology to help users determine whether abnormalities found in breast tissue are malignant. The unit is in clinical trials to explore its efficacy as an adjunct to mammography and clinical examination.
The deal is part of CTIs ongoing effort to strengthen its business. In June, the Layton, UT, company consolidated its subsidiary, Thermal Medical Imaging, into its operations, a move it hoped would eliminate confusion about the two companies and their relationship to each other, as well as streamline CTIs management and accounting functions (SCAN 6/9/99).
In other CTI news, the company has received approval from the Food and Drug Administration for the first module of a five-part pre-market approval application (PMA) for its breast cancer detection system. The remaining modules of the application are being prepared and will be submitted as they are completed, according to the company. CTIs PMA covers the use of its device as an adjunct to mammography. The firm is conducting trials with the unit at five hospitals across the U.S.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.